Ongoing Clinical Trials Abstracts

Abstract OT-21-01: Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM)

Pub Date : 2021-02-15 DOI: 10.1158/1538-7445.sabcs20-ot-21-01 I. Acerbi, A. Fiscalini, Mandy Che, Yiwey Shieh, L. Madlensky, J. Tice, E. Ziv, M. Eklund, Amie M. Blanco, B. Tong, D. Goodman, L. Nassereddine, N. Anderson, H. Harvey, Steele Fors, H. Park, Antonia Petruse, S. Stewart, J. Wernisch, L. Risty, Ian Hurley, B. Koenig, Celia Kaplan, Robert Hiatt, Neil S. Wenger, Vivian Lee, D. Heditsian, S. Brain, L. Sabacan, Tianyi Wang, B. Parker, A. Borowsky, H. Anton-Culver, A. Naeim, A. Kaster, M. Talley, L. J. van ’t Veer, A. LaCroix, O. Olopade, Deepa Sheth, Augustin Garcia, R. Lancaster, L. Esserman

Abstract OT-33-01: Combination ipatasertib and atezolizumab to prevent recurrence in triple negative breast cancer(TNBC): A phase II single arm trial

Pub Date : 2021-02-15 DOI: 10.1158/1538-7445.SABCS20-OT-33-01 E. Mittendorf, S. Tolaney, P. Wileyto, M. Demeo, H. Rugo, R. Nanda, I. Mayer, B. Park, Heather MacArthur, Angela DeMichelle

Abstract OT-28-06: A phase 1, first in human study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor in subjects with HER2 overexpressing solid tumors

Pub Date : 2021-02-15 DOI: 10.1158/1538-7445.sabcs20-ot-28-06 N. Grover, D. Barton, A. Ronczka, J. Bauml